Baig Mirza Zain, Abdullah Umm E Hani, Muhammad Aun, Aziz Abeer, Syed Maryam Jamil, Darbar Aneela
Department of Surgical Oncology, Dyson Cancer Center, Health Quest Health Systems/Nuvance Health, Poughkeepsie, NY, USA.
Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.
Asian Spine J. 2021 Feb;15(1):117-126. doi: 10.31616/asj.2019.0161. Epub 2020 Mar 13.
Low back pain (LBP) is a common problem encountered by physicians. It is a considerable cause of morbidity and socioeconomic loss and is one of the most expensive musculoskeletal disorders. Conventional treatments include bed rest, analgesics, therapeutic exercises, lumbar or caudal epidural corticosteroids, and surgery. Several new biological therapies are being investigated for use in LBP and one of these is platelet-rich plasma (PRP). In this article, we summarize the current literature published on PRP concerning its composition, classification, and application in LBP. We believe our review will prove useful to clinicians and academics alike, interested in new developing therapies for LBP.
腰痛（LBP）是医生们经常遇到的一个常见问题。它是发病率和社会经济损失的一个重要原因，也是最昂贵的肌肉骨骼疾病之一。传统治疗方法包括卧床休息、止痛药物、治疗性锻炼、腰椎或骶管硬膜外皮质类固醇注射以及手术。目前正在研究几种用于治疗腰痛的新型生物疗法，其中之一是富血小板血浆（PRP）。在本文中，我们总结了目前已发表的关于PRP的文献，内容涉及PRP的组成、分类及其在腰痛治疗中的应用。我们相信，我们的综述将对那些对腰痛新疗法感兴趣的临床医生和学者都有所帮助。
